Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ·Healthcare·Biotechnology
$4.66
-1.38%
Mkt Cap $53.91M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$13.25
Range $10.00 – $17.00
Implied Upside
+184.6%
Consensus $13.25 vs current $4.66
NASDAQ·Healthcare·Biotechnology
$4.66
-1.38%
Mkt Cap $53.91M
No recent rating data.
Price Target (4 analysts)
$13.25
Range $10.00 – $17.00
+184.6%
Consensus $13.25 vs current $4.66